Generative AI is reshaping drug discovery by predicting protein structures, designing antibodies, and making GPCRs targetable. Learn how GenAI shortens timelines and opens new therapies.
GenAI’s Breakthrough in Drug Discovery: Drugging GPCRs and Other Undruggable Targets Read More »
Explore how CareLoop, Peak:AIO and Audiebant are shaping AI in UK healthcare, with NHS adoption and investment from groups like PXN Group.
UK AI Healthcare Innovations: CareLoop, Peak:AIO, Audiebant Leading the Way Read More »
At JPM 2026 Bora Pharmaceuticals and EirGenix unveiled AI-driven manufacturing, US onshoring, continuous production and biosimilar partnerships reshaping Taiwan’s biopharma role.
Taiwan Biotech Leaders Embrace AI and Advanced Manufacturing at JPM 2026 Read More »
A concise overview of AI developments in UK healthcare: NHS App trial access, NHS England’s digital strategy, and legislative ethics shaping AI use.
AI in UK Healthcare: NHS App, Strategic Direction and the Ethics Debate Read More »
A concise update on how AI is reshaping dermatopathology, its strengths for melanoma and common lesions, limits with rare diseases, and the path to safe clinical adoption.
AI in Skin Diagnostics: What Clinicians and Investors Need to Know Read More »
The UK can lead AI healthcare regulation with lifecycle rules, a high-risk tier, assurance cases and an AI Yellow Card to protect patients and speed adoption.
UK’s Urgent Opportunity: Shaping World-Class AI Regulation in Healthcare Read More »
How AI is applied to Traditional Chinese Medicine: tongue scanners, pulse readers, molecular mapping, and government-backed expansion, with limits and human oversight.
AI and Traditional Chinese Medicine: Diagnostics, Research, and Limits Read More »
A concise reality check on how patients experience AI in NHS care, the risks users face, administrative gaps, accessibility issues, and five guiding principles for safe deployment.
AI in the NHS: Public Experiences and the Road to Responsible Integration Read More »
Insilico Medicine and Qilu Pharmaceutical launched a strategic collaboration using Chemistry42 and Biology42 to discover cardiometabolic drug candidates. Read a concise analysis of what this deal means for AI adoption in pharma.
NHS launches a pilot using AI to detect lung nodules and robotics to guide biopsies. Read how the tech works and what it could mean for earlier cancer diagnosis.
